Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-25T11:26:55.266Z Has data issue: false hasContentIssue false

33 - Skin cancer other than melanoma

Published online by Cambridge University Press:  23 December 2009

Sankha Suvra Mitra
Affiliation:
Consultant, Clinical Oncologist, The Sussex Cancer Centre, Royal Sussex County Hospital, Brighton and Sussex University Hospitals, NHS Trust, Brighton, East Sussex, UK
Louise Hanna
Affiliation:
Velindre Hospital, Cardiff
Tom Crosby
Affiliation:
Velindre Hospital, Cardiff
Fergus Macbeth
Affiliation:
Velindre Hospital, Cardiff
Get access

Summary

Introduction

Skin cancer is a common cancer, and it is often caused by ultraviolet radiation from chronic sun exposure in a fair-skinned population. Basal cell carcinoma is the most frequent variety, and presents as a superficial tumour that very rarely metastasises. Squamous cell carcinoma can spread to regional lymph nodes.

For the management of skin cancer, patients are usually discussed in a multidisciplinary team meeting. Surgical excision is the treatment of choice for the majority of tumours. Non-surgical treatment options include radiotherapy, curettage, imiquimod cream, photodynamic therapy, and topical 5-FU therapy. Radiotherapy is an important treatment option for older patients – it is preferred to surgery for large superficial tumours, multiple tumours, and in areas around the eye, nose, and ear where the cosmetic results may be better. The radiotherapy technique involves treatment with either superficial X-rays or electron therapy. Cure rates are about 95% at 5 years.

The National Institute for Health and Clinical Excellence has recently published service guidance on the care of these patients (NICE, 2006).

Range of tumours

In the differential diagnosis of a skin tumour, the tumour could be benign or malignant, and a malignant tumour could be primary or secondary.

Premaligant conditions

Premalignant conditions include the following (Soutar and Robertson, 2001):

  • Actinic keratosis.

  • Bowen's disease.

  • Erythroplasia of Queyrat.

  • Paget's disease.

Benign tumours

Benign tumours include the following:

  • Benign naevus.

  • Sebaceous cyst.

  • Epidermal cyst.

  • Basal cell papilloma (seborrhoeic keratosis).

  • Vascular angioma.

  • Keratoacanthoma.

  • Dermatofibroma.

Malignant tumours

Primary malignant tumours include:

  • Basal cell carcinoma.

  • […]

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Cancer Society. (2003). Cancer Facts and Figures. Atlanta: American Cancer Society.
Avril, M. F., Auperin, A., Margulis, A.et al. (1997). Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br. J. Cancer, 76, 100–6.CrossRefGoogle Scholar
Caccialanza, M., Piccinno, R., Moretti, D.et al. (2003). Radiotherapy of carcinomas of the skin overlying the cartilage of the nose: results in 405 lesions. Eur. J. Dermatol., 13, 462–5.Google ScholarPubMed
Dabski, K. and Helm, F. (1988). Topical chemotherapy. In Skin Cancer: Recognition and Management, ed. Schwartz, R. A.. New York: Springer-Verlag, pp. 378–89.CrossRefGoogle Scholar
Diepgen, T. L. and Mahler, V. (2002). The epidemiology of skin cancer. Br. J. Dermatol., 146 (Suppl. 61), 1–6.CrossRefGoogle ScholarPubMed
Dobbs, J., Barrett, A. and Ash, D. (1999). Practical Radiotherapy Planning, 3rd edn. London: Arnold, pp. 149–64.Google Scholar
Lebwohl, M., Dinehart, S., Whiting, D.et al. (2004). Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomised, double-blind, parallel group, vehicle-controlled trials. J. Am. Acad. Dermatol., 50, 714–21.CrossRefGoogle Scholar
Lovett, R. D., Perez, C. A., Shapiro, S. J.et al. (1990). External irradiation of epithelial skin cancer. Int. J. Radiat. Oncol. Biol. Phys. 19, 235–42.CrossRefGoogle ScholarPubMed
Malhotra, R., Huilgol, S. C., Huynh, N. T.et al. (2004). The Australian Mohs database, part II. Periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology, 111, 631–6.CrossRefGoogle ScholarPubMed
National Comprehensive Cancer Network. (2005). Basal and squamous cell skin cancer guideline. In The Complete Library of National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, version 1. Jenkintown, PA: National Comprehensive Cancer Network (cluster of differentiation-ROM).
National Institute for Health and Clinical Excellence. (2006). Improving Outcomes for People with Skin Tumours Including Melanoma. London: National Institute for Health and Clinical Excellence.
Rubin, A. I., Chen, E. H. and Ratner, D. (2005). Basal-cell carcinoma. N. Engl. J. Med., 353, 2262–9.CrossRefGoogle ScholarPubMed
Safai, B. (1997). Kaposi's sarcoma and acquired immunodeficiency syndrome. In aquired immune deficiency syndrome: Epidemiology, Diagnosis, Treatment and Prevention, ed. DeVita, V. T., Hellman, S. and Rosenberg, S., 4th edn. Philadelphia, PA: Lippincott-Raven, pp. 295–358.Google Scholar
Solan, M. J., Brady, L. W., Binnick, S. A. et al. (1997). Skin. In Principles and Practice of Radiation Oncology, ed. Perez, C. A. and Brady, L. W., 3rd edn. Philadelphia, PA: Lippincott-Raven, pp. 723–44.Google Scholar
Soutar, D. S. and Robertson, A. G. (2001). Skin cancer other than melanoma. In Oxford Textbook of Oncology, 2nd edn. Oxford: Oxford University Press, pp. 1235–43.Google Scholar
Thomas, R. M. and Amonette, R. A. (1998). Mohs micrographic surgery. Am. Fam. Physician, 37, 135–42.Google Scholar
Tran, H., Chen, K. and Shumack, S. (2003). Summary of actinic keratosis studies with imiquimod 5% cream. Br. J. Dermatol., 149 (Suppl. 66), 37–9.CrossRefGoogle ScholarPubMed
International Union Against Cancer. (2002). tumour nodes metastases Classification of Malignant Tumours, ed. Sobin, L. H. and Wittekind, Ch., 6th edn. New York: Wiley-Liss, pp. 123–5.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×